SYNERGY BETWEEN HIGH-DOSE CYTARABINE AND ASPARAGINASE IN THE TREATMENT OF ADULTS WITH REFRACTORY AND RELAPSED ACUTE MYELOGENOUS LEUKEMIA - A CANCER AND LEUKEMIA GROUP-B STUDY

被引：69
|
作者：
CAPIZZI, RL
DAVIS, R
POWELL, B
CUTTNER, J
ELLISON, RR
COOPER, MR
DILLMAN, R
MAJOR, WB
DUPRE, E
MCINTYRE, OR
机构：
[1] HARVARD UNIV, SCH PUBL HLTH, BOSTON, MA 02115 USA
[2] CUNY MT SINAI SCH MED, NEW YORK, NY 10029 USA
[3] COLUMBIA UNIV, SCH MED, NEW YORK, NY 10027 USA
[4] UNIV CALIF SAN DIEGO, SCH MED, LA JOLLA, CA 92093 USA
[5] DARTMOUTH COLL, HITCHCOCK MED CTR, DARTMOUTH MED SCH, HANOVER, NH 03756 USA
[6] WALTER REED ARMY HOSP, WASHINGTON, DC USA
[7] FRONTIER SCI, BUFFALO, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1988年 / 6卷 / 03期
关键词：
D O I：
10.1200/JCO.1988.6.3.499
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：499 / 508
页数：10
相关论文
共 50 条
  • [1] High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia
    Cortes, J
    Estey, E
    O'Brien, S
    Giles, F
    Shen, Y
    Koller, C
    Beran, M
    Thomas, D
    Keating, M
    Kantarjian, H
    CANCER, 2001, 92 (01) : 7 - 14
  • [2] HIGH-DOSE CYTARABINE IN ACUTE MYELOGENOUS LEUKEMIA
    ZITTOUN, R
    BONE MARROW TRANSPLANTATION, 1989, 4 : 38 - 42
  • [3] IDARUBICIN AND HIGH-DOSE CYTARABINE IN THE TREATMENT OF REFRACTORY AND RELAPSED ACUTE LYMPHOBLASTIC-LEUKEMIA
    GIONA, F
    TESTI, AM
    AMADORI, S
    MELONI, G
    CAROTENUTO, M
    RESEGOTTI, L
    COLELLA, R
    LEONI, P
    CARELLA, AM
    GROTTO, P
    MINIERO, R
    MANDELLI, F
    ANNALS OF ONCOLOGY, 1990, 1 (01) : 51 - 55
  • [4] TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOGENOUS LEUKEMIA WITH HIGH-DOSE CYTOSINE-ARABINOSIDE
    HOFELER, H
    ANDERS, CU
    POPESCU, O
    HOFFKEN, K
    SCHMIDT, CG
    TUMORDIAGNOSTIK & THERAPIE, 1987, 8 (06) : 220 - 224
  • [5] HIGH-DOSE CYTARABINE (HD-ARA-C) IN REFRACTORY AND RELAPSED ADULT ACUTE MYELOGENOUS LEUKEMIA (AML)
    HOFELER, H
    ANDERS, CU
    POPESCU, O
    HOFFKEN, K
    SCHMIDT, CG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 209 - 209
  • [6] High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902
    Stone, Richard M.
    Moser, Barry
    Sanford, Ben
    Schulman, Philip
    Kolitz, Jonathan E.
    Allen, Steven
    Stock, Wendy
    Galinsky, Ilene
    Vij, Ravi
    Marcucci, Guido
    Hurd, David
    Larson, Richard A.
    LEUKEMIA RESEARCH, 2011, 35 (03) : 329 - 333
  • [7] HIGH-DOSE CYTARABINE AND DAUNORUBICIN INDUCTION AND POSTREMISSION CHEMOTHERAPY FOR THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN ADULTS
    PHILLIPS, GL
    REECE, DE
    SHEPHERD, JD
    BARNETT, MJ
    BROWN, RA
    FREILAHR, DA
    KLINGEMANN, HG
    BOLWELL, BJ
    SPINELLI, JJ
    HERZIG, RH
    HERZIG, GP
    BLOOD, 1991, 77 (07) : 1429 - 1435
  • [8] COMBINATION CHEMOTHERAPY WITH DIAZIQUONE AND AMSACRINE IN RELAPSED AND REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA - A CANCER AND LEUKEMIA GROUP-B STUDY
    SCHIFFER, CA
    DAVIS, RB
    MAYER, RJ
    PETERSON, BA
    LEE, EJ
    CANCER TREATMENT REPORTS, 1987, 71 (09): : 879 - 880
  • [9] AMSACRINE WITH HIGH-DOSE CYTARABINE IS HIGHLY EFFECTIVE THERAPY FOR REFRACTORY AND RELAPSED ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
    ARLIN, ZA
    FELDMAN, E
    KEMPIN, S
    AHMED, T
    MITTELMAN, A
    SAVONA, S
    ASCENSAO, J
    BASKIND, P
    SULLIVAN, P
    FUHR, HG
    MERTELSMANN, R
    BLOOD, 1988, 72 (02) : 433 - 435
  • [10] RISK-FACTORS FOR HIGH-DOSE CYTARABINE NEUROTOXICITY - AN ANALYSIS OF A CANCER AND LEUKEMIA GROUP-B TRIAL IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    RUBIN, EH
    ANDERSEN, JW
    BERG, DT
    SCHIFFER, CA
    MAYER, RJ
    STONE, RM
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (06) : 948 - 953
12345